| Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | May 4th, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | May 4th, 2024 06:18PM | May 4th, 2024 06:18PM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | May 3rd, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | May 3rd, 2024 02:43PM | May 3rd, 2024 02:43PM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | May 2nd, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | May 2nd, 2024 09:32AM | May 2nd, 2024 09:32AM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | May 1st, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | May 1st, 2024 09:07AM | May 1st, 2024 09:07AM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | Apr 30th, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | Apr 30th, 2024 07:57AM | Apr 30th, 2024 07:57AM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | Apr 29th, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | Apr 29th, 2024 09:10AM | Apr 29th, 2024 09:10AM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | Apr 28th, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | Apr 28th, 2024 04:12PM | Apr 28th, 2024 04:12PM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | Apr 26th, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | Apr 26th, 2024 07:58AM | Apr 26th, 2024 07:58AM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | Apr 25th, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | Apr 25th, 2024 06:14PM | Apr 25th, 2024 06:14PM | Eloxx Pharmaceuticals | |||||||||||||||||||||
| nasdaq:elox | https://www.glassdoor.com?employer_id=2095475 | 2095475 | Apr 24th, 2024 12:00AM | Open | Eloxx Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 3.40 | 100% | 55% | 48% | 3.60 | 3.30 | 3.10 | 3.80 | 3.70 | 3.50 | 1.00 | 1.00 | 1.00 | 3.00 | 4.00 | 1.00 | 33.333% | 33.333% | 33.333% | 0.00 | 0.00 | 9.00 | Open | Greg Williams | Apr 24th, 2024 10:42AM | Apr 24th, 2024 10:42AM | Eloxx Pharmaceuticals |